ULTRAGENYX PHARMACEUTICAL INC. - COMMON STOCK

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

19 أبريل 2023 16:01:00 بحسب Nasdaq GlobeNewswire

Ultragenyx to Present at Guggenheim’s Genomic Medicines and Rare Disease Days

28 مارس 2023 16:01:00 بحسب Nasdaq GlobeNewswire

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

21 مارس 2023 08:30:00 بحسب Nasdaq GlobeNewswire

Ultragenyx Appoints Dr. Eric Crombez Chief Medical Officer and Executive Vice President

14 مارس 2023 08:30:00 بحسب Nasdaq GlobeNewswire

Ultragenyx to Participate in Orphan Neuro Panel at Cowen Healthcare Conference

28 فبراير 2023 16:01:00 بحسب Nasdaq GlobeNewswire

Ultragenyx Reports Fourth Quarter and Full Year 2022 Financial Results and Corporate Update

16 فبراير 2023 16:01:00 بحسب Nasdaq GlobeNewswire

Ultragenyx to Host Conference Call for Fourth Quarter and Full-Year 2022 Financial Results and Corporate Update

09 فبراير 2023 16:01:00 بحسب Nasdaq GlobeNewswire

Ultragenyx Reports Preliminary 2022 Revenue; Guidance for 2023 Revenue and Cash Usage; Pipeline Updates and 2023 Milestones

06 يناير 2023 16:01:00 بحسب Nasdaq GlobeNewswire

Ultragenyx to Present at the 41st Annual J.P. Morgan Healthcare Conference

04 يناير 2023 06:00:00 بحسب Nasdaq GlobeNewswire

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

21 ديسمبر 2022 16:01:00 بحسب Nasdaq GlobeNewswire

Ultragenyx to Present at Piper Sandler Healthcare Conference

22 نوفمبر 2022 16:01:00 بحسب Nasdaq GlobeNewswire

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

18 نوفمبر 2022 16:05:00 بحسب Nasdaq GlobeNewswire

Ultragenyx Announces Departure of Chief Financial Officer

10 نوفمبر 2022 16:15:00 بحسب Nasdaq GlobeNewswire

Ultragenyx to Present at Upcoming Healthcare Conferences

09 نوفمبر 2022 16:01:00 بحسب Nasdaq GlobeNewswire

Ultragenyx Reports Third Quarter 2022 Financial Results and Corporate Update

02 نوفمبر 2022 16:05:01 بحسب Nasdaq GlobeNewswire

Ultragenyx to Host Conference Call for Third Quarter 2022 Financial Results and Corporate Update

27 أكتوبر 2022 16:01:00 بحسب Nasdaq GlobeNewswire

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

04 أكتوبر 2022 16:30:00 بحسب Nasdaq GlobeNewswire

Ultragenyx and Mereo BioPharma to Present Setrusumab Data Update at ASBMR

09 سبتمبر 2022 20:22:15 بحسب Nasdaq GlobeNewswire

Ultragenyx to Participate at Citi BioPharma Conference

01 سبتمبر 2022 16:01:00 بحسب Nasdaq GlobeNewswire

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

17 أغسطس 2022 16:01:00 بحسب Nasdaq GlobeNewswire